Food and Drug Administration approvals in phase 3 Cancer clinical trials

BACKGROUND: Phase 3 oncologic randomized clinical trials (RCTs) can lead to Food and Drug Administration (FDA) approvals. In this study, we aim to identify trial-related factors associated with trials leading to subsequent FDA drug approvals. METHODS: We performed a database query through the Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Abi Jaoude, Joseph, Kouzy, Ramez, Ghabach, Marc, Patel, Roshal, Pasalic, Dario, Ghossain, Elie, Miller, Austin B., Lin, Timothy A., Verma, Vivek, Fuller, C. David, Subbiah, Vivek, Minsky, Bruce D., Ludmir, Ethan B., Taniguchi, Cullen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196526/
https://www.ncbi.nlm.nih.gov/pubmed/34118915
http://dx.doi.org/10.1186/s12885-021-08457-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196526/
https://www.ncbi.nlm.nih.gov/pubmed/34118915
http://dx.doi.org/10.1186/s12885-021-08457-5

Ejemplares similares